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The UK Renal Registry (UKRR) was established by the Renal Association in 1995 with the primary aim 
of collating data centrally from all adult UK renal centres to improve the care of patients with end-
stage kidney disease. It is therefore unlike many other national audits, which are run by the 
Healthcare Quality Improvement Partnership. Although originally limited to patients on renal 
replacement treatments – dialysis therapies and kidney transplant recipients – it now collects all 
cases of acute kidney injury (AKI) in primary and secondary care and all cases of advanced chronic 
kidney disease in secondary care not on dialysis. Children on renal replacement treatments were 
initially captured by a separate registry established by the British Association for Paediatric 
Nephrology, but this activity passed over to the UKRR from 2009.  
The UKRR is funded principally through an annual capitation fee levied on renal centres for each 
dialysis and transplant patient. The main output of the UKRR is an annual quality assurance report 
that is distributed to the wider renal community with patient-friendly plain English summaries also 
available. The data are also used with appropriate permissions for research. 
How does the UKRR collect data? 
The Bristol-based UKRR team of about 25 data analysts, statisticians and researchers manage data 
collection on approximately 7,000 new patients and 55,000 existing patients on renal replacement 
treatments each year (Gilg et al., 2017, MacNeill and Ford, 2017). Data items collected are listed on 
the UKRR website (www.renalreg.org/data/). The UKRR has support under section 251 of the Health 
and Social Care Act to collect these data for audit and research purposes without individual patient 
consent (Caskey et al., 2017). Data are collected on a quarterly basis from all renal centres via 
automatic downloads (figure 1). English, Welsh and Northern Irish renal centres send their data 
directly to the UKRR, where much work is undertaken to identify and resolve errors and 
inconsistencies before detailed statistical analyses are conducted. Scottish data are collected, 
validated and published by the Scottish Renal Registry before they are shared with the UKRR. The 
process of data collection is likely to change significantly in the future with the launch of the UK 
Renal Data Collaboration (UKRDC), which aims to standardise UK-wide data collection and storage, 
enabling more real time analyses and outputs from the UKRR (Caskey et al., 2017).  
What are UKRR data used for?  
The UKRR has entered an exciting phase of its development with data now used not only for audit 
purposes, but also for research, quality improvement and innovation through the Think Kidneys 
programme, and clinical informatics.  
1. Audit 
The 19th annual report was published in September 2017. While the majority of the chapters 
report long term data, new or revised chapters are written each year that focus on novel 
ways of analysing and presenting the data. The report is available on the UKRR website 
  
(https://www.renalreg.org/publications-reports/) and is used by health professionals, 
commissioners, patients and the public to view individual renal unit performance against 
national standards.  
2. Research 
The UKRR is open to requests from clinicians, researchers and statisticians 
(www.renalreg.org/about-us/working-with-us/). It provides large data sets for 
epidemiological and exploratory analyses and efficient outcome data for clinical trials. The 
UKRR is currently leading two NIHR-HTA funded randomised controlled trials: (i) the Prepare 
for Kidney Care study randomises older comorbid patients approaching end-stage kidney 
disease to either prepare for responsive management or prepare for dialysis (Caskey, 
2017a); and (ii) the High-volume Haemodiafiltration vs High-flux Haemodialysis Registry Trial 
randomises patients to two different types of dialysis (Caskey, 2017b). Registry-based trials 
offer the potential to efficiently answer questions that could not only improve patient 
outcomes, but also standardise care nationally. By being nested within the entire patient 
population, they also help us understand any selection biases in recruitment to the trial, so 
that the generalisability of the results to routine practice can be fully understood. In 
addition, formal quality improvement evaluations (Gallagher et al., 2017) and research 
projects (Pruthi et al., 2016, Birnie et al., 2017) are undertaken by research fellows, 
statisticians and external researchers. The UKRR has also been a powerful tool for 
monitoring equity of access to dialysis (Judge et al., 2012) and transplantation (Udayaraj et 
al., 2012). 
3. Improvement and innovation through the Think Kidneys programme  
The UKRR has now worked together with NHS England on three national Think Kidneys 
programmes to improve the care of people with, or at risk of, kidney disease 
(https://www.thinkkidneys.nhs.uk/):  
(i) The AKI programme raised awareness of AKI by improving access to education, 
developing effective resources and sharing best practice across the NHS and beyond. 
More than 80% of laboratories in England now submit AKI data from primary and 
secondary care to the UKRR (figure 1). The focus of future work at the UKRR will be 
to combine these data with linked data on hospitalisation and mortality to facilitate 
ongoing surveillance of AKI outcomes.  
(ii) The Transforming Participation in Chronic Kidney Disease (TPCKD) programme 
supported people with kidney disease to make decisions about their health that 
improve their quality of life. Patient reported outcome measures and levels of 
patient activation have been successfully collected in 14 renal centres. Work 
continues to test interventions that may improve an individual’s outcome. 
(iii) The Kidney Quality Improvement Partnership (KQuIP) works to improve the lives of 
people affected by kidney disease by supporting healthcare professionals, kidney 
units, renal networks and commissioners to achieve the highest quality of care for 
patients (figure 2). 
4. Clinical informatics  
(i) The UKRDC is a new process for collecting data for kidney patients, whereby data 
will flow into a central data repository and flow out to various organisations with 
approved access to the data. Advantages of the UKRDC include real time data access 
and processing, standardised processing and nomenclature and the ability to link 
quickly with other databases. 
(ii) PatientView is a mobile-friendly platform that gives patients real time access to 
much of the information in their renal electronic health record. Daily updates 
  
including blood results, medication lists and letters on the local renal IT systems flow 
securely through the UKRR to a website that patients can log onto (figure 1). Exciting 
developments are the ability of patients to contact their kidney team directly, as 
well as being able to feedback important information on how their kidney disease is 
impacting their lives. 
(iii) The National Registry of Rare Kidney Diseases (RaDaR) is a Renal Association 
initiative coordinated by the UKRR that brings data of patients with certain rare 
kidney diseases together (figure 1). RaDaR provides clinicians with an invaluable 
resource to accelerate research and presents patients with opportunities to 
participate in research.  
What challenges does the UKRR face? 
Medicine is evolving rapidly, as is the technology that clinicians and patients have become 
accustomed to using in their day-to-day lives. The challenge is to process, analyse and report data as 
quickly as possible to ensure outputs are clinically meaningful and help engage patients in the 
ongoing management of their kidney conditions. Combining improved data processing with external 
data linkages to Hospital Episode Statistics and the Office for National Statistics will allow much 
more detailed analyses and help the UKRR remain an integral part of research into the many 
unanswered questions in nephrology. Opportunities include post-marketing surveillance of drugs 
and monitoring patient quality of life as they transition onto and change modalities of renal 
replacement treatments. Patient engagement is vital and the evolution of patients’ involvement in 
their own care such as with PatientView is likely to be rapid. The guardianship of patient data will 
also continue to be a major challenge. Collaboration across national borders is likely to accelerate, as 
will the sharing of best practice with the developing world. Clearly many challenges lie ahead, but 
these are exciting times for national audits and registries. 
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Key points 
• The UKRR collects data on all patients receiving renal replacement therapy in the UK via 
automatic downloads from renal centres. 
• The UKRR recently started to collect AKI and advanced CKD data, which will greatly improve 
our understanding of how patients progress to end-stage kidney disease. 
• The UKRR produces an annual report that health professionals, commissioners, patients and 
the public can use to view individual renal unit performance against national standards. 
• In addition to audit purposes, patient data are also used for research, quality improvement 
and innovation through the Think Kidneys programme, and clinical informatics. 
• A future challenge for the UKRR is to process, analyse and report data more quickly to 
ensure outputs are clinically meaningful and help engage patients in the ongoing 
  
management of their kidney conditions. 
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Figure 1 A schematic of data flows between hospital labs, renal centres and registry databases (SRR, Scottish 
Renal Registry; UKRR, UK Renal Registry; PV, PatientView; RaDaR, National Registry of Rare Kidney Diseases). 
*The UKRR collects data on paediatric patients for the British Association for Paediatric Nephrology 
 
 
Figure 2 Founding members of the KQuIP (RA, Renal Association; BRS, British Renal Society; BTS, British 
Transplantation Society; BAPN, British Association for Paediatric Nephrology; KRUK, Kidney Research UK; NKF, 
National Kidney Federation) 
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